Investigators compared oncologic outcomes among patients with tumors in the bladder only vs in the bladder neck/urethra.

Treatment recommendations for all stages of bladder cancer have been proposed in the form of clinical guidelines from the European Association of Urology and the American Urological Association.

Opens in a new tab or window In patients with suspected muscle-invasive bladder cancer (MIBC), definitive ... staged MIBC still underwent TURBT for histologic clarification." ...

Detecting Early Recurrence With Circulating Tumor DNA in Stage I-III Biliary Tract Cancer After Curative Resection Somatic ... Baseline clinical and demographic features were compared across ...

High-risk, non-muscle-invasive bladder cancer is defined as any transitional cell carcinoma (TCC) of the bladder that is high-grade, whether it is primary or recurrent. This high-risk group ...

Bladder cancer affects over 52,000 men and women in the United States on an annual basis, and more than 12,000 people die each year from this disease. It is the fourth most common cancer in men in ...

Bavencio improved survival in patients with bladder cancer, irrespective of diabetes status, according to an analysis of the ...

Bladder cancer is the 11th most common cancer in the UK, accounting for 3% of all new cancer cases (2017-2019).[1-4] In females in the UK, bladder cancer is the 17th most common cancer (2% of all new ...

Complete response: the disappearance of cancer. The data that were submitted to the FDA showed that, among 88% and 82% of subjects, the probability of avoiding surgery to remove their bladder was ...

Hussein, MD, of Roswell Park Comprehensive Cancer Center in Buffalo ... embryologic origin and a different histology compared with the rest of the urinary bladder. Among 608 patients at their ...